|
RAPGEF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.59089999995921E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.18370000024015E-07 |
| Normal-vs-Stage2 |
1.606170E-01 |
| Normal-vs-Stage3 |
4.837800E-03 |
| Normal-vs-Stage4 |
1.627800E-04 |
| Stage1-vs-Stage2 |
5.450100E-02 |
| Stage1-vs-Stage3 |
5.312000E-01 |
| Stage1-vs-Stage4 |
4.669600E-01 |
| Stage2-vs-Stage3 |
2.853400E-01 |
| Stage2-vs-Stage4 |
7.126500E-02 |
| Stage3-vs-Stage4 |
3.361800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.85039999948067E-07 |
| Normal-vs-AfricanAmerican |
3.561600E-04 |
| Normal-vs-Asian |
5.400800E-04 |
| Caucasian-vs-AfricanAmerican |
5.295400E-01 |
| Caucasian-vs-Asian |
3.399400E-01 |
| AfricanAmerican-vs-Asian |
2.318800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.161999999999E-06 |
| Normal-vs-Female |
5.239700E-04 |
| Male-vs-Female |
4.915800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.225900E-04 |
| Normal-vs-Extreme_Weight |
2.19829999981158E-07 |
| Normal-vs-Obese |
3.156300E-03 |
| Normal-vs-Extreme_Obese |
5.811800E-04 |
| Normal_Weight-vs-Extreme_Weight |
5.313400E-01 |
| Normal_Weight-vs-Obese |
4.567800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.787000E-01 |
| Extreme_Weight-vs-Obese |
9.692000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.720400E-01 |
| Obese-vs-Extreme_Obese |
2.596600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.045390E-01 |
| Normal-vs-Age(41-60Yrs) |
2.209300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.49130000015596E-07 |
| Normal-vs-Age(81-100Yrs) |
1.224320E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.263600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.469200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.164200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.578300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.605800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.568200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.40560000031032E-07 |
| Normal-VS-Type2 PRCC |
3.629800E-04 |
| Normal-VS-KIRP CIMP |
2.540200E-02 |
| Normal-VS-Unclassified PRCC |
3.446000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.292600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.759200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.933900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.153000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.032220E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.729800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.55460000000174E-05 |
| Normal-vs-N1 |
6.41209999999726E-05 |
| Normal-vs-N2 |
1.219820E-02 |
| N0-vs-N1 |
8.714200E-01 |
| N0-vs-N2 |
8.083600E-01 |
| N1-vs-N2 |
8.367600E-01 |
|
|
